Laigo Bio in a €5.5M seed extension with Biovance Capital, Kurma Partners, w/ Curie Capital, Argobio, Angelini Ventures, Eurazeo, Oncode Bridge Health services Pharma Investments 08 March 2026 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 6.51M Round investors: EurazeoROM Utrecht RegionArgobioCancer Research HorizonsBiovance Capital PartnersAngelini VenturesCurie CapitalKurma Life Science PartnersOncode Oncology Bridge Fund Company: Laigo Bio Industry: Health servicesPharma
Pan Cancer raises €5M with InnovationQuarter, Thuja Capital, Van Herk Ventures and Erasmus MC in the Netherlands Biotech Health services Pharma Investments 02 December 2025